Newsroom > In the News
In the news
News headlines are articles that reference ResMed's company, people, or business practices.
June 13, 2017Sleep Review
A large study finds that ASV yields better compliance among obstructive sleep apnea patients who develop treatment-emergent central sleep apnea than does CPAP. Researchers discuss why and what it means in clinical practice.
June 13, 2017Medical Devices
This presentation is a must for anyone who wants to understand how dramatically the smart use of big data can impact the entire healthcare system. With ResMed’s investments in digitization, they are lowering costs for sleep apnea and COPD therapy and increasing patient adherence.
June 9, 2017Sleep Review
Boosted by launches [like ResMed's AirMini], the market for small positive airway pressure devices has never been bigger.
June 7, 2017mHealth Intelligence
Healthcare providers are using mobile health technology to transform clunky CPAP devices into high-tech mHealth platforms, giving doctors better insight into sleep and breathing problems.
June 5, 2017Bloomberg (starts at 27:40)
ResMed Chief Medical Officer Carlos M. Nunez, M.D., discussed sleep apnea, why ResMed connected 3 million sleep devices to the cloud, and his thoughts on sleep trackers, with Bloomberg Baystate Business Hour host Anne Mostue.
Recognition and treatment of sleep-disordered breathing: an important component of chronic disease managementMay 25, 2017Journal of Translational Medicine
The recognition and treatment of sleep-disordered breathing is vital for the continued health and wellbeing of individual patients with SDB.
May 22, 2017PCHAlliance
The Personal Connected Health Alliance (PCHAlliance) today announced the addition of twelve new member companies during the first quarter of 2017, including five at the Global level -- AT&T, Eli Lilly and Company, IPSOS Healthcare, ResMed and Samsung. As a Global Member, each had the opportunity to nominate an executive to the PCHAlliance Board of Managers and all have been accepted.
May 21, 2017MedPage Today
Patients with persistent hypercapnia following an acute exacerbation of chronic obstructive pulmonary disease (COPD) had a longer time to death or rehospitalization if non-interventional ventilation was added to their home oxygen therapy, researchers found.
For Patients With Treatment-emergent Central Sleep Apnea, Switching from CPAP to ASV Significantly Improves ComplianceMay 16, 2017Sleep Review
ResMed Inc announced that people with obstructive sleep apnea who develop central sleep apnea (CSA) are more compliant on therapy after they switch from continuous positive airway pressure (CPAP) therapy to adaptive servo-ventilation (ASV) therapy, according to the largest-ever analysis of patients with treatment-emergent CSA.
May 8, 2017Becker's Hospital Review
Amy Cook, Director of Healthcare Informatics at ResMed, was named to Becker's list of 110 Women in Medtech to Know in 2017. Joining ResMed in 2012, she was integral in developing and rolling out the company's suite of connected health IT services and platforms.